Search

Your search keyword '"Kubica, Jacek"' showing total 1,008 results

Search Constraints

Start Over You searched for: Author "Kubica, Jacek" Remove constraint Author: "Kubica, Jacek"
1,008 results on '"Kubica, Jacek"'

Search Results

1. The pitchfork bifurcation and heteroclinic connections in the Kuramoto--Sivashinsky PDE

2. Efficacy and Safety of P2Y12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials

4. Conley-Morse-Forman theory for generalized combinatorial multivector fields on finite topological spaces

5. Lefschetz Complexes as Finite Topological Spaces

7. Enhanced Inflammation is a Marker for Risk of Post-Infarct Ventricular Dysfunction and Heart Failure.

11. Persistent Homology of Morse Decompositions in Combinatorial Dynamics

12. Repetitive use of LEvosimendan in Ambulatory Heart Failure patients (LEIA-HF) - The rationale and study design

13. Lipoprotein (a) and the Occurrence of Lipid Disorders and Other Cardiovascular Risk Factors in Patients without Diagnosed Cardiovascular Disease.

14. A Systematic Review and Meta-Analysis of the Diagnostic Value of Galectin-3 in Acute Coronary Syndrome.

15. Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis—DM-Dragon Registry.

16. Sex Differences in Fractional Flow Reserve Utilization.

17. Diagnostic and prognostic performance of neutrophil-to-lymphocyte ratio in acute coronary syndromes: A meta-analysis of 90 studies including 45 990 patients

18. Cangrelor — Expanding therapeutic options in patients with acute coronary syndrome

19. First-year follow-up costs of myocardial infarction management in Poland from the payer’s perspective

20. Proposal and Practicality of an Alternative Blue-Light Hazard Risk Assessment Method for High Intensity White-Light Sources at Workplaces

21. Gender-Related Effectiveness of Personalized Post-COVID-19 Rehabilitation

24. Recommendations of the Experts of the Polish Cardiac Society (PCS) and the Polish Lipid Association (PoLA) on the diagnosis and management of elevated lipoprotein(a) levels.

25. Strategy of lipid-lowering treatment in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint

26. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

27. Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVR

30. Survival in nonagenarians with acute myocardial infarction in 2014–2020: A nationwide analysis

31. Recommendations of Polish Cardiac Society expert regarding the use of andexanet alpha in the Polish context. An interdisciplinary protocol

32. Elevated serum transaminases in patients with acute coronary syndromes: Do we need a revision of exclusion criteria for clinical trials?

33. TCT-596 Sex Differences in Use of Fractional Flow Reserve in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention

34. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

36. Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease – A meta-analysis

38. A systematic review and meta-analysis of the impact of the pandemic on dispatcher-assisted cardiopulmonary resuscitation.

39. Impact of early levosimendan administration in patients with decompensated chronic heart failure on oxidative stress parameters -- the rationale and study design.

40. The use of andexanet alpha in the Polish setting: An interdisciplinary protocol Expert consensus statement of the Polish Cardiac Society.

44. Urologia. Ilustrowany podręcznik dla studentów i stażystów

45. Determinants of Lipid Parameters in Patients without Diagnosed Cardiovascular Disease—Results of the Polish Arm of the EUROASPIRE V Survey

46. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy

49. PLATELET-TO-LYMPHOCYTE RATIO AS A PROGNOSTIC BIOMARKER FOR COVID-19 SEVERITY: A SINGLE CENTER RETROSPECTIVE DATA ANALYSIS AND SYSTEMATIC REVIEW WITH META-ANALYSIS OF 187 STUDIES.

50. Management of myocardial infarction complicated by cardiogenic shock: Expert opinion of the Association of Intensive Cardiac Care and Association of Cardiovascular Interventions of the Polish Society of Cardiology.

Catalog

Books, media, physical & digital resources